Table 5.
Group | n | SBM ≥ 3/w | SBM < 3/w | P value | Difference | 95% CI |
---|---|---|---|---|---|---|
XEBT group | 335 | 291 (86.87%) | 44 (13.13%) | 0.0001 | 55.96% | 46.4%, 65.52% |
Placebo group | 110 | 34 (30.91%) | 76 (69.09%) |
Group | n | SBM ≥ 3/w | SBM < 3/w | P value | Difference | 95% CI |
---|---|---|---|---|---|---|
XEBT group | 335 | 291 (86.87%) | 44 (13.13%) | 0.0001 | 55.96% | 46.4%, 65.52% |
Placebo group | 110 | 34 (30.91%) | 76 (69.09%) |